OTX 015

Based on 345 reference(s) in Google Scholar 10 10 345

Axon 2530

CAS [202590-98-5]

MF C25H22ClN5O2S
MW 491.99

Purity: 99%
Optical purity: Optically pure
Soluble in DMSO and ethanol

OTX 015

Description

Potent inhibitor of BRD2, BRD3, and BRD4 (Ki values ranging from 3.2 to 24.7 nM, considering BDs 1 and 2), with clear anti-proliferative activity on a large number of diffuse large B-cell lymphoma (DLBCL) cell lines. OTX 015 inhibits the growth of hematologic malignances through directly regulating MYC expression and activity.

M. Boi et al. The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.Clin Cancer Res. 2015 Apr 1;21(7):1628-38.

J. Lu et al. Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chem Biol. 2015 Jun 18;22(6):755-63.

X. Ran et al. Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors. J Med Chem. 2015 Jun 25;58(12):4927-39.

Potent inhibitor of BRD2, BRD3, and BRD4 with clear anti-proliferative activity

Chemical name

(S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide

Parent CAS No.

[202590-98-5]

Order

Size	Unit Price	Stock
5 mg	€110.00	In Stock
25 mg	€370.00	In Stock

Need more? Bulk Inquiry

Related Products

Axon ID	Name	Description
1887	PFI-1	BET bromodomain (BRD) inhibitor	€75.00
1989	(+)-JQ1	Potent and selective BET bromodomain inhibitor	€60.00
2245	RVX 208	BET bromodomain inhibitor specific for second bromodomains (BD2s)	€65.00
2410	GSK 5959	Potent, cell permeable inhibitor of BRPF1 bromodomain	€135.00
2594	CPI 0610	Selective and metabolically stable inhibitor of BET bromodomains	Inquire
2776	CD161	Potent, selective, and orally active BET bromodomain inhibitor	€135.00
3037	BET BRD4 inhibitor compound II-25	Potent, selective and orally active BET inhibitor	€165.00
3329	ODM-207	Highly potent, selective and orally active pan-BET inhibitor	€140.00
3623	SGC-SMARCA-BRDVIII	Potent, highly selective and cell-active SMARCA2/4 and PB1(5) bromodomain inhibitor	€90.00
3716	BMS-986158	BET bromodomain (BRD) inhibitor	Inquire
3696	ABBV-075	Highly potent and orally bioavailable BET bromodomain (BRD) inhibitor	€110.00
3833	AZD5153 HNT salt	Potent, selective, and orally available BET/BRD4 bromodomain inhibitor	Inquire
3860	I-BET726	Potent and selective, tetrahydroquinoline-based small molecule ligand binding to BET proteins	Inquire
3822	(+)-JQ1 carboxylic acid	(+)-JQ1 derivative; PROTAC precursor	€110.00
3921	GSK046	Domain-selective and orally active inhibitor of BET with immunomodulatory activity	Inquire
3922	dBET1	BET bromodomain degrader	Inquire
3933	CCS-1477	Potent, selective and orally bioavailable inhibitor of the Bromodomain of p300 and CBP	Inquire
3944	ARV-825	Potent and selective protein BRD4 degrader	Inquire
3956	ABBV-744	First-in-class potent, selective and orally bioavailable BET BD2 inhibitor	€120.00
3873	(-)-JQ-1	Inactive enantiomer of (+)-JQ1	€120.00
4134	I-BET762	BET bromodomain inhibitor	Inquire
4135	I-BET151	BET bromodomain inhibitor	Inquire
4192	(S)-BI 2536	Dual PLK1/BRD4 bromodomain inhibitor	€170.00
4131	DW-71177	Potent, orally bioavailable and BD1-selective BET inhibitor	€160.00

Customer Support

Customer Services

About Axon Medchem

Contact Us

OTX 015

Description

Chemical name

Parent CAS No.

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Customer Support

Customer Services

About Axon Medchem

Contact Us

OTX 015

Description

Chemical name

Parent CAS No.

Related Products

Customer Support

About Axon Medchem

Download Product Catalog

Follow Us

Send us a message

Contact Us